Cat. No.: X24-07-ZQ876
Cysteine protease inhibitor LHVS, Purity ≥98%
Synonym: 170111-28-1; Cysteine protease inhibitor
- CAS Number: 170111-28-1
- Compound CID: 5287864
Properties
Description
LHVS obstructs cysteine proteases, enzymes implicated in numerous diseases due to their role in protein degradation. It targets Cathepsin B, cathepsin K, cathepsin L, and cathepsin S.
Molecular Weight
527.68
Molecular Formula
C28H37N3O5S
Targets
Cathepsin B; cathepsin K; cathepsin L; Cathepsin S
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
LHVS is employed to block cysteine protease activity, which plays a role in protein catabolism and related diseases.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
- Cysteine protease inhibitor MK-0822, Purity ≥98%
- Cathepsin inhibitor 1, Purity ≥98%
- Cysteine protease inhibitor Balicatib, Purity ≥98%
- Cysteine protease inhibitor CA-074, Purity ≥98%
- Cysteine protease inhibitor E-64, Purity ≥98%
- Cysteine protease inhibitor E64-C, Purity ≥98%
Quick Links
PRODUCTS
GalNAc-L96 intermediate, T1 (Cat#: X24-11-YM010)
GalNAc-L96 intermediate, T2 (Cat#: X24-11-YM011)
GalNAc-L96 intermediate, T3 (Cat#: X24-11-YM012)
GalNAc-L96 intermediate, T4-Amine (Cat#: X24-11-YM014)
Tri-GalNAc(OAc)3 Cbz (Cat#: X24-11-YM015)
Tri-GalNAc(OAc)3 (Cat#: X24-11-YM016)
Tri-GalNAc(OAc)3 TFA (Cat#: X24-11-YM017)
GalNAc-L96-OH (Cat#: X24-11-YM018)
GalNAc-L96-TEA (Cat#: X24-11-YM019)
Neu5Gcα(2-6)N-Glycan (Cat#: X23-03-YW036)
A2G2 N-Glycan (Cat#: X23-03-YW037)
A2G2S2 N-Glycan (Cat#: X23-03-YW038)
A2 N-Glycan (Cat#: X23-03-YW039)
A2[6]G1 N-Glycan (Cat#: X23-03-YW040)
M3 N-Glycan (Cat#: X23-03-YW041)
A2[3]G2S1 N-Glycan (Cat#: X23-03-YW042)
Core 2 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW178)
Core 2 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW179)
Core 3 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW180)
Core 3 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW181)
Core 4 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW182)
T antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW192)
T antigen O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW193)
Tn antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW194)
Blood group A trisaccharide (Cat#: XCO0060Q)
Blood group B trisaccharide (Cat#: XCO0068Q)
Blood group H disaccharide (Cat#: XCO0074Q)
Lewis A trisaccharide (Cat#: XCO0079Q)
3'-Sulfated lewis A (Cat#: XCO0080Q)
Lewis B tetrasaccharide (Cat#: XCO0083Q)
Lewis X trisaccharide (Cat#: XCO0085Q)
Lewis Y tetrasaccharide (Cat#: XCO0088Q)
Lacto-N-biose (Cat#: XCO0089Q)
2'-Fucosyllactose (Cat#: XCO0091Q)
3-Fucosyllactose (Cat#: XCO0092Q)
Lactodifucotetraose (Cat#: XCO0093Q)
Lacto-N-triose I (Cat#: XCO0094Q)
3'-Sialyllactose sodium salt (Cat#: XCO0096Q)
6'-Sialyllactose sodium salt (Cat#: XCO0098Q)
3'-Sialyl-3-fucosyllactose (Cat#: XCO0100Q)
Heparin amine, MW 27 kDa (Cat#: X22-09-ZQ478)
FITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ480)
TRITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ481)
Biotin-heparin-FITC, MW 18 kDa (Cat#: X22-09-ZQ482)
Chondroitin sulfate (dp4) (Cat#: X22-11-ZQ598)
Dermatan sulfate (dp12) (Cat#: X22-11-ZQ611)
Heparin disaccharide I-A (Cat#: X22-11-ZQ662)
Chondroitine sulfate (Cat#: X23-04-XQ1118)
GalNAcβ(1-4)GlcNAcβ-Sp3-Biotin (Cat#: X22-12-ZQ005)
GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-Biotin (Cat#: X22-12-ZQ006)
GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-FITC (Cat#: X22-12-ZQ007)
GalNAcβ(1-4)GlcNAcβ-Sp3-PAA (Cat#: X22-12-ZQ008)
Glcβ(1-4)GalNAcα-Sp3-Biotin (Cat#: X22-12-ZQ037)
Glcβ(1-4)GalNAcα-Sp3-PAA-Biotin (Cat#: X22-12-ZQ038)
Glcβ(1-4)GalNAcα-Sp3-PAA-FITC (Cat#: X22-12-ZQ039)
Glcβ(1-4)GalNAcα-Sp3-PAA (Cat#: X22-12-ZQ040)
GlcCer (d18:1/8:0) (Cat#: X23-11-ZQ101)
GalCer (d18:1/16:0) (Cat#: X23-11-ZQ112)
LacCer (d18:1/8:0) (Cat#: X23-11-ZQ118)
Lc3Cer (d18:1/8:0) (Cat#: X23-11-ZQ131)
Lc4Cer (d18:1/12:0) (Cat#: X23-11-ZQ146)
Sialyl-Lc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ162)
Lewis a Cer (d18:1/16:0) (Cat#: X23-11-ZQ175)
nLc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ190)
Methyl-γ-cyclodextrin (DS 12) (Cat#: X23-11-YM119)
Carboxymethyl-ɑ-cyclodextrin sodium salt (Cat#: X23-11-B003)
Carboxymethyl-γ-cyclodextrin sodium salt (Cat#: X23-11-B004)
Succinyl-ɑ-cyclodextrin (Cat#: X23-11-B005)
Succinyl-γ-cyclodextrin (Cat#: X23-11-B006)
ɑ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B007)
β-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B008)
γ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B009)
Lysine-dextran, MW 4 kDa (Cat#: X22-09-ZQ273)
Phenyl-dextran, MW 150 kDa (Cat#: X22-09-ZQ279)
FITC-Q-dextran, MW 10 kDa (Cat#: X22-09-ZQ280)
FITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ283)
TRITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ287)
FITC-dextran sulfate, MW 10 kDa (Cat#: X22-09-ZQ291)
Dextran amine, MW 20 kDa (Cat#: X22-09-ZQ377)
TRITC-dextran, MW 40 kDa (Cat#: X22-09-ZQ383)
Biotin-dextran-FITC, MW 20 kDa (Cat#: X22-09-ZQ389)
Online Inquiry